Intravitreal versus sub-Tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema

Ophthalmologica

Volumn 225, Issue 4, 2011, Pages 222-227

  Yalcinbayir, Ozgur ^a   Gelisken, Oner ^a   Kaderli, Berkant ^a   Avci, Remzi ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Diabetes; Edema; Macular edema, diffuse diabetic; Triamcinolone

Indexed keywords

TRIAMCINOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; DIABETIC PATIENT; DRUG EFFICACY; FEMALE; HUMAN; INJECTION SITE; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; PROSPECTIVE PAYMENT; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TENON CAPSULE; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 79952340210     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324714     Document Type: Article

References (32)

1. Diabetic Retinopathy Clinical Research Network (DRCR.net): Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2009;127:245-251.
2. Blankenship GW: Diabetic macular edema and argon laser photocoagulation: a prospective randomized study. Ophthalmology 1979;86:69-75. (Pubitemid 9171538)
3. McDonald HR, Schatz H: Grid photocoagulation of diffuse macular edema. Retina 1985;5:65-72. (Pubitemid 15004310)
4. Olk RJ: Modified grid argon (blue-green) laser photocoagulation for diffuse macular edema. Ophthalmology 1986;93:938-948.
5. Diabetic Retinopathy Clinical Research Network: Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-1077.
6. Jonas JB, Sofker A: Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-427. (Pubitemid 32768624)
7. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C: Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927. (Pubitemid 34465226)
8. Moshfeghi DM, Kaiser PK, Scott IU: Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-796. (Pubitemid 37330020)
9. Jonas JB, Kreissig I, Degenring R: Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol 2003;121:729-730. (Pubitemid 36554480)
10. Helm CJ, Holland GN: The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995;120:55-64.
11. Thach AB, Dugel PU, Flindall RJ: A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology 1997;104:2003-2008. (Pubitemid 28053425)
12. Kaur C, Foulds WS, Ling EA: Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res 2008;27:622-647.
13. Massin P, Audren F, Haouchine B: Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004;111:218-224. (Pubitemid 38183217)
14. Jonas JB, Kreissig I, Sofker A, Degenring RF: Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61. (Pubitemid 36401766)
15. Cardillo JA, Melo LA Jr, Costa RA, Skaf M, Belfort R Jr, Souza-Filho AA, Farah ME, Kuppermann BD: Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 2005;112:1557-1563. (Pubitemid 41725412)
16. Bonini-Filho MA, Jorge R, Barbosa JC, Calucci D, Cardillo JA, Costa RA: Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Invest Ophthalmol Vis Sci 2005;46:3845-3849. (Pubitemid 44264695)
17. Bakri SJ, Kaiser PK: Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema. Am J Ophthalmol 2005;139:290-294. (Pubitemid 40288274)
18. Cellini M, Pazzaglia A, Zamparini E, Leonetti P, Campos E: Intravit real vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema. BMC Ophthalmol 2008;8:5.
19. Iwao K, Inatani M, Kawaji T, Koga T, Mawatari Y, Tanihara H: Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection. J Glaucoma 2007;16:251-256. (Pubitemid 46673362)
20. Smithen LM, Ober MD, Maranan L, Spaide RF: Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 2004;138:740-743. (Pubitemid 39452920)
21. Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA: Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 2005;112:593-598. (Pubitemid 41108858)
22. Wingate RJ, Beaumont PE: Intravitreal triamcinolone and elevated intraocular pressure. Aust NZ J Ophthalmol 1999;27:431-432. (Pubitemid 30040169)
23. Mueller AJ, Jian G, Banker AS, Rahhal FM, Capparelli E, Freeman WR: The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure. Am J Ophthalmol 1998;125:158-163. (Pubitemid 28081292)
24. Shukla D, Vidhya N, Prasad NM, Mahalakshmi R, Kolluru C, Krishnadas R: Eva luation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone. Am J Ophthalmol 2007;144:453-454. (Pubitemid 47331385)
25. Yamamoto Y, Komatsu T, Koura Y, Nishino K, Fukushima A, Ueno H: Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection. Can J Ophthalmol 2008;43:42-47. (Pubitemid 351269567)
26. Inatani M, Iwao K, Kawaji T, Hirano Y, Ogura Y, Hirooka K, Shiraga F, Nakanishi Y, Yamamoto H, Negi A, Shimonagano Y, Sakamoto T, Shima C, Matsumura M, Tanihara H: Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study. Am J Ophthalmol 2008;145:676-681.
27. Lau LI, Chen KC, Lee FL, Chen SJ, Ko YC, Liu CJ, Hsu WM: Intraocular pressure elevation after intravitreal triamcinolone acetonide injection in a Chinese population. Am J Ophthalmol 2008;146:573-578.
28. Galor A, Margolis R, Brasil OM, Perez VL, Kaiser PK, Sears JE, Lowder CY, Smith SD: Adverse events after intravitreal triamcinolone in patients with and without uveitis. Ophthalmology 2007;114:1912-1918. (Pubitemid 47483933)
29. Rhee DJ, Peck RE, Belmont J, Martidis A, Liu M, Chang J, Fontanarosa J, Moster MR: Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol 2006;90:999-1003. (Pubitemid 44140181)
30. Hirooka K, Shiraga F, Tanaka S, Baba T, Mandai H: Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone. Jpn J Ophthalmol 2006;50:235-238. (Pubitemid 43881998)
31. Zaka-ur-Rab S, Mahmood S, Shukla M, Zakir SM, Khan BA, Owais M: Systemic absorption of triamcinolone acetonide after posterior sub-Tenon injection. Am J Ophthalmol 2009;148:414-419.
32. Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, Mitchell P, Sharp D, Wolf-Schnurrbusch UE, Gekkieva M, Weichselberger A, Wolf S: Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010;33:2399-2405.